-
Transcriptomic analysis of the Phase 3 COMPARZ clinical trial
Study
EGAS00001004534
-
Targeted sequencing of Burkitt lymphoma tumour samples from the UK's Haematological Malignancy Research Network
Study
EGAS00001004649
-
Evolutionary dynamics of residual disease in human glioblastoma
Study
EGAS00001003043
-
Investigate the evolutionary trajectories during invasiveness acquisition in early lung adenocarcinoma
Study
EGAS00001004754
-
Rna-Seq Leiomyosarcoma subtypes
Study
EGAS00001004783
-
Clinical Implications of Genomic Alterations in the Tumor and Circulation of Pancreatic Cancer Patients
Study
EGAS00001001257
-
Search for new loci and low-frequency variants influencing glioma risk by exome-array analysis
Study
EGAS00001001258
-
Spatial genomic heterogeneity in multiple myeloma revealed by multi- region sequencing
Study
EGAS00001002111
-
The Genetic Landscape of BCL2 Break Negative Follicular Lymphoma
Study
EGAS00001002164
-
WES used for direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
Study
EGAS00001002050